DSMBs in Adaptive Trials with Roger Lewis

In this episode of "In the Interim…", host Dr. Scott Berry is true to the name of the podcast, as he discusses the unblinded world of adaptive clinical trials alongside Dr. Roger Lewis, a renowned expert in both statistical science and clinical medicine. Together, they explore the critical role of Data Safety Monitoring Boards (DSMBs) in safeguarding trial integrity and participant safety specifically for adaptive trials. The discussion navigates the complexities and challenges faced by DSMBs, particularly in adaptive trial contexts, offering valuable insights for anyone involved in clinical trial science. Key Highlights • Overview of the fundamental role and responsibilities of DSMBs in clinical trials. • Discussion on how DSMBs ensure scientific integrity and participant safety in adaptive trials. • Differences in DSMB involvement between traditional and adaptive trial designs. • The evolving skillset required for DSMB members in the context of complex, adaptive trials. • Exploration of the critical collaboration between DSMBs and Statistical Analysis Committees. Quotes • "The DSMB is tasked with balancing efficacy and safety at a very fundamental level." — Roger Lewis • "Adaptive trials expand the role of the DSMB to ensure trials are conducted as intended." — Roger Lewis • "The DSMB needs to review efficacy and safety to appropriately balance them." — Roger Lewis